For the U.S. bioeconomy to prosper and boom, the U.S. needs to land on a single, working definition of the bioeconomy while considering the role of sustainability in order to be competitive at the global scale.
The U.S. is facing a shortage in both pilot-scale and manufacturing-scale biomanufacturing facilities that severely hinders product development and commercialization.
Amino acids are essential but costly inputs for large-scale bioproduction. Federal funding can incentivize scalable production, cutting these costs in half.
Here are industry leaders’ top three takeaways from this year’s Advanced Bioeconomy Leadership Conference.
The past year has been an exciting time for the bioeconomy as U.S. government agencies work to update their approaches and improve coordination to better support bio-based products and processes.
To strengthen the U.S. lead in the bioeconomy, Congress recently passed the CHIPS & Science Act of 2022. While the main body of this bill is related to semiconductors, this bill also lays out a solid base for the bioeconomy. Shortly after the passing of the CHIPS & Science Act, the White House also published an Executive Order that […]
Over the past year, there have been significant policy advances related to the US bioeconomy—the part of the economy driven by the life sciences and biotech, and enabled by engineering, computing, and information science.1 The bioeconomy includes a wide range of products and processes, from mRNA vaccines and drought-resistant crops to microbial fertilizers and bioindustrial fermentation. […]
The COVID-19 pandemic has highlighted the essential importance of biomanufacturing capabilities—extending to the geopolitical level—as well as the fragility of many supply chains and processes.
The U.S. government should create a Bio for America Program Office (BAPO) at the National Institute for Standards and Technology (NIST) to house a suite of initiatives that would lead to the creation of more well-paying U.S.-based biomanufacturing jobs and more.
Streamlined funding of open and cross-disciplinary research, prize and challenge mechanisms, and market shaping through innovative procurement have all proven highly effective in the face of market failures and applied technology gaps like those seen in our bioindustry.
For the United States, the economic, societal, and national security benefits of the life sciences are vast. The U.S. bioeconomy – the part of the economy driven by the life sciences and biotech, and enabled by engineering, computing, and information science – is valued at over $950 billion. Life sciences research leads to cleaner crops […]
Plants are key to enable a diversified and climate-resilient food system. Mary Fernandes proposes a Plant Genome Project (PGP), a robust Human Genome Project-style initiative to build a dataset of genetic information on plant species.